Systematic Reviews
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Jan 15, 2022; 14(1): 334-347
Published online Jan 15, 2022. doi: 10.4251/wjgo.v14.i1.334
Table 3 Potential therapeutic targets
Exosomal content
Sample
Expression
Content identification
Animal model (Yes/No)
Function
Ref.
HCC
Proteins
ENO1Cancer cells-exosomes, tissue (n = 94)Up IHC stainingYPromotes HCC growth, metastasis, and further patient deterioration[57]
miRNAs
miR-125a/bTAMs-exosomes Tissue (n = 6)Down qRT-PCRNA possible therapeutic target in HCC[58]
miR-150-3pFibroblasts-exosomes, tissues (n = 82)DownqRT–PCRNAbrogate HCC migration and invasiveness[59]
miR-32-5pBel/5-FU-exosomes, tissue (n = 72)Up qRT–PCRYInduce multidrug resistance in HCC[60]
miR-320aCancer cells-exosomes, tissue (n = 6) Down qRT–PCRYMediates HCC tumor progression[61]
miR-3682-3pCancer cells-exosomes, tissue (n = 8)Down qRT–PCRYAttenuate angiogenesis and provides novel potential targets for liver cancer therapy[62]
miR-378bCancer cells-exosomes, tissue (n = 105)Up qRT–PCRYEnhance HCC cell progression and angiogenesis[63]
lncRNAs
ASMTL-AS1Cancer cells-exosomes, tissues (n = 70)Up qRT–PCRYAggravate the malignancy in residual HCC [64]
PCED1B-AS1Cancer cells-exosomes, tissues (n = 45)Up qRT–PCRYInduce immunosuppression in HCC[65]
circRNAs
circRNA Cdr1asCancer cells-exosomes, tissues (n = 42)Up qRT–PCRYPromote the progression of HCC by sponging miR-1270 to upregulate AFP level[66]